Pharos Capital
·
Pharos IV
·
RhythMedix
Cardiac remote patient monitoring.
Company Profile
FUND
Pharos IV
Status
Current
Year of Investment
2023
location
Mt. Laurel, NJ
sector
Medical Devices / Remote Patient Monitoring
strategic focus
Continuous cardiac monitoring with built-in cellular connectivity
RhythMedix is a medical device manufacturer and wireless medical technology company providing innovative technology to transform the cardiac monitoring industry and improve patient outcomes. RhythmStar is the first wearable cardiac monitor with built-in cellular connectivity, allowing physicians and their patients to remain continuously and comfortably connected for faster arrhythmia detection. Powerful proprietary algorithms alongside the RhythMedix Independent Diagnostic Testing Facility (IDTF) evaluate every heartbeat, providing actionable reporting for healthcare providers.
Other Companies in Our Portfolio
Three Ways to Work with Pharos
Whether you're allocating capital or building a healthcare company, we start with the same question: does this serve the communities that need it most?
Investors
Pharos partners with foundations, family offices, and institutional investors who want competitive returns from healthcare companies serving underserved communities.
Founders & Operators
We invest $25 to $50 million in established, U.S.-based healthcare companies positioned to reduce disparities in underserved communities and scale toward a potentially successful exit. If your company fits that profile, we want to hear from you.
Healthcare Partners
If you are a payor, hospital, health system, or governmental agency that services rural, tribal, or other complex underserved populations, we would welcome the opportunity to share existing solutions we have identified or to use our network to source new solutions for the problems these communities face.